Split-course radiotherapy: Where do we stand?

Strahlentherapie und Onkologie

Volumn 177, Issue 5, 2001, Pages 227-239

  Dubben, Hans Hermann ^a   Krüll, Andreas ^a   Beck Bornholdt, Hans Peter ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Evidence based radiotherapy; Publication bias; Randomized trials; Split course radiotherapy; Treatment interruptions

Indexed keywords

CANCER RADIOTHERAPY; CLINICAL PRACTICE; CLINICAL TRIAL; EVIDENCE BASED MEDICINE; HUMAN; MEDICAL INFORMATION; META ANALYSIS; PUBLICATION; REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0035016083     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00002402     Document Type: Review

References (129)

1. Split-course vs continuous-course irradiation in the post-operative setting of squamous cell carcinoma of the head and neck
2. The effect of overall treatment time on local control in patients with adenocarcinoma of the prostate treated with radiation therapy
3. Altered fractionation schedules
4. Radical irradiation with the split-course technique in carcinoma of the lung
5. Age as a prognostic indicator in carcinoma of the lung
6. Postoperative split course radiotherapy of squamous cell carcinoma of the oral tongue
7. The effect of treatment time and treatment interruption on tumor control following radical radiotherapy of laryngeal cancer
8. A multivariate primary tumor control analysis in 465 patients treated by radical radiotherapy for cancer of the tonsillar region: Clinical and treatment factors as prognositic factors
9. Consequential late reactions as dose limiting factor in radiation oncology. Book of abstracts
10. Is there sufficient evidence for accelerated repopulation in tumors during radiotherapy?
11. Potential pitfalls in the use of p-values and in interpretation of significance levels
12. Rebuttal: Is gambling a serious alternative to evidence-based medicine?
13. No reliable evidence for accelerated repopulation in tumours during continuous fractionated radiotherapy
14. Multiple signifikanztests und ihre bedeutung bei der beurteilung von resultaten
15. Clinical radiobiology of squamous cell carcinoma of the oropharynx
16. Time-dose relationships for human tumors: Estimation from non-rando-mized studies
17. Time-dose relationships in radiotherapy
18. Radiobiological considerations in the design of clinical trials
19. Why actuarial estimates should be used in reporting late normal-tissue effects of cancer treatment ... now!
20. Radiotherapeutic management of primary thyroid lymphoma
21. Tumor cell repopulation in the rest interval of split-course radiation treatment
22. Carcinoma of the nasopharynx: Results of radiation treatment and some prognostic factors
23. Conclusion of the symposium on protraction and fractionation
24. Treatment of glioblastoma multiforme. A review
25. Carcinomas of the anterior tonsillar pillar and the soft palate-uvula: Treatment by radiation therapy
26. Combination chemo-radiotherapy for residual recurrent or inoperable carcinoma of the rectum: ECOG study (EST 3276)
27. Changes in the rate of repopulation during multifraction irradiation of mouse skin
28. Radiotherapy for T2 and T3 carcinoma of the bladder: The influence of overall treatment time
29. Three A's of repopulation during fractionated irradiation of squamous epithelia: Asymmetry loss, acceleration of stem-cell divisions and abortive divisions
30. Tumor volume: A basic and specific response predictor in radiotherapy
31. Was ist power und warum ausgerechnet 80%
32. Aktuarische auswertung von zeit-ereignis-daten und ihre bedeutung bei der beurteilung von resultaten
33. Radiation therapy in Ewing's sarcoma: An update of the CESS trial
34. Publication bias in clinical research
35. Dose, time, and fractionation: A clinical hypothesis
36. Radical radiation therapy of advanced lung cancer: Evaluation of prognostic factors and results of continuous and split-course treatment
37. En-bloc irradiation of unresectable bronchogenic carcinomas and their regional lymphatics
38. Early-stage squamous cell carcinoma of the glottic larynx managed with radiation therapy
39. Loss of local control with prolongation in radiotherapy
40. The importance of beta, the type II error, and sample size in the design and interpretation of the randomized control trial. Survey of 71 negative trials
41. The importance of beta, the type II error, and sample size in the design and interpretation of the randomized controlled trial
42. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimen for advanced head and neck cancer: Results of RTOG 88-09
43. Results of radical radiation therapy in clinical stage I, technically operable non-small cell lung cancer
44. Importance of overall treatment time for the outcome of radiotherapy of advanced head and neck carcinoma: Dependency on tumor differentiation
45. Radiation therapy for stage I and II laryngeal cancer using 10 MV X-rays or cobalt-60 gamma-rays
46. The effect of overall treatment time of radiation therapy on local control of T1-stage squamous cell carcinoma of the glottis
47. Survival in carcinoma of the lung after a split course of radiotherapy
48. Laryngeal carcinoma IV. Analysis of treatment results using the Cohen model
49. Radiation reaction in the lung after continuous and split-course megavoltage radiotherapy of bronchial carcinoma
50. Split-course radiotherapy of cancer
51. Clinical experience with split-course radiotherapy. A randomized clinical trial
52. A randomized study of split-course radiotherapy of lung cancer: Long term results
53. Split-course vs continuous radiotherapy. Analysis of a randomized trial
54. Erfahrungen über die verträglichkeitsgrenze für röntgenstrahlen und deren nutzanwendung zur verhütung von schäden
55. Pharyngo-cutaneous fistulae after laryngectomy. Influence of previous radiotherapy and prophylactic metronidazole
56. Split-course radiotherapy of Hodgkin's disease: Local tumor control and normal tissue reactions
57. 60Co irradiation
58. Effect of split-course radiotherapy on survival and local control in advanced localized prostatic carcinoma
59. Effect of overall treatment time on local control in radical radiotherapy for squamous cell carcinoma of esophagus
60. Non parametric estimation from incomplete observation
61. A comparison of high-dose continuous and split-course irrad-iation in non-oat-cell carcinoma of the lung
62. Radical radiation therapy with 5-fluorouracil infusion and mitomycin C for oesophageal squamous carcinoma
63. A randomized trial of radiation therapy compared to split course radiation therapy combined with mitomycin-c and 5-fluorouracil as initial treatment for advanced laryngeal and hypopharyngeal squamous carcinoma
64. Split course irradiation compared to split course irradiation plus hydroxyurea in inoperable bronchogenic carcinoma - A randomised study of 53 patients
65. Comparison of split-course radiation therapy and continuous radiation therapy for unresectable bronchogenic carcinoma: 5 year results
66. Discrepancies between meta-analyses and subsequent large randomized, controlled trials
67. Local tumor control in radiation therapy of cancers in the head and neck
68. Split-course radiotherapy in the treatment of carcinoma of the esophagus
69. Evaluation of unplanned interruptions in radiotherapy treatment schedules
70. Squamous cell carcinoma of the oropharynx. Results of primary radiotherapy
71. Comparison of continuous and split-course radiotherapy for nasopharyngeal carcinoma
72. Comparison of continuous and split-course radiotherapy for nasopharyngeal carcinoma - An analysis of 1446 cases with squamous cell carcinoma grade 3
73. The influence of the number of fractions and of overall treatment time on local control and late complication rate in squamous cell carcinoma of the larynx
74. Split course radiation in in-operable carcinoma of the bronchus
75. Pilot study of dose fractionation in carcinoma of the base of the tongue: Uninterrupted vs. split-course irradiation
76. Split-course radiation therapy of carcinoma of the nasopharynx: Results of a national collaborative clinical trial of the radiation therapy oncology group
77. Split-course vs continuous pelvis irradiation in carcinoma of the uterine cervix: A propective randomized clinical trial of the radiation therapy oncology group
78. Split-course radiation therapy of carcinoma of the base of tongue: Results of a prospective national collaborative clinical trial conducted by the radiation therapy oncology group
79. Split-course radiotherapy of carcinoma of the urinary bladder stages C and D1
80. Compensated split-course vs continuous radiation therapy of carcinoma of the tonsillar fossa - Final results of a prospective randomized clinical trial of the radiation therapy oncology group
81. T2 oral tongue carcinoma treated with radiotherapy: Analysis of local control and complications
82. Evaluation of University of FLorida split-course technique for various head and neck squamous cell carcinomas
83. Results of radiotherapy in nasopharyngeal cancer. A retrospective comparison of split-course and continuous-course treatment schedules
84. Comparison of conventional and spilt-course radiotherapy as primary treatment in carcinoma of the larynx
85. About tolerance and quality. An important notice to all radiation oncologists
86. Elapsed treatment days - A critical item for radiotherapy quality control review in head and neck trials: RTOG report
87. A re-evaluation of spit-course technique for squamous cell carcinoma of the head and neck
88. An evaluation of spilt-course irradiation for pelvic malignancies
89. Continuous or split-course combined external and intracavitary radiotherapy of locally advanced carcinoma of the uterine cervix
90. Prognostic value of pre-treatment factors in patients with locally advanced carcinoma of the uterine cervix treated by radiotherapy alone
91. A prospective randomised trial study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung
92. Impact of tumor control on survival in carcinoma of the lung treated with irradiation
93. Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the radiation therapy oncology group
94. Local control and reduced complications in split course irradiation of prostatic cancer
95. Hydroxyurea as a radiation sensitizer in women with carcinoma of the uterine cervix
96. Der fehler zweiter art und seine bedeutung bei der beurteilung von resultaten
97. Report of a prospective trial - Split course vs conventional radiotherapy in the treatment of non-small cell lung cancer
98. Predictors of radiation response in lung cancer. A clinico-pathobiological analysis
99. The assessment of tumor response to irradiation of lung cancer: Continuous vs split-course regimes
100. Split-course radiotherapy for urinary bladder cancer
101. Split-course radiation therapy in malignant tumors
102. The effect of mitotic suppression and recovery after irradiation on time-dose relationships and the application of this effect to clinical radiation therapy
103. The results of split-course radiation therapy in cancer of the lung
104. Treatment outcome following radiotherapy in elderly patients with bladder cancer
105. Comparison of dose-time-fractionation schemes in non-oat cell lung cancer
106. Looking through the retrospectoscope in the era of evidence-based medicine
107. Increased chronic bowel complications with split-course pelvic irradiation
108. Clinical trials in cancer
109. Palliative radiotherapy for inoperable carcinoma of the lung: Final report of a RTOG multi-institutional trial
110. Planned and unplanned gaps in radiotherapy: The importance of gap position and gap duration
111. Hypofractionated radiation therapy in unresectable stage III non-small cell lung cancer
112. Effect of rest interval on tumor and normal tissue response - A report of phase III study of accelerated split course palliative radiation for advanced pelvic malignancies (RTOG-8502)
113. Changes in tumor oxygenation during combined treatment with split-course radiotherapy and chemotherapy in patients with head and neck cancer
114. Dose-time considerations of head and neck squamous cell carcinomas treated with irradiation
115. Dose, time, and fraction size issues for late effects in head and neck cancers
116. Does tumor control decrease by prolonging overall treatment time or interrupting treatment in laryngeal cancer?
117. Dose, fractionation and overall treatment time in radiation therapy - The effects on local control for cancer of the larynx
118. Pharyngo-cutaneous fistulae after laryngectomy
119. Primary radiotherapy of T1 squamous cell carcinoma of the larynx: Analysis of 478 patients treated from 1963 to 1985
120. End results of radiation therapy, alone and combination with 5-fluorouracil in colorectal cancers
121. Local control of oropharyngeal carcinoma after two accelerated hyperfractionation radiation therapy schemes
122. The hazard of accelerated tumor clonogen repopulation during radiotherapy
123. Biologic basis of radiation therapy
124. Radiation treatment of carcinoma of the oropharynx. Report on 201 patients